Core Viewpoint - The article discusses the recent controversy surrounding Juzi Biotechnology, particularly allegations of false advertising regarding its collagen products, leading to a significant drop in its stock price and market value [1][3][6]. Group 1: Allegations and Company Response - A beauty influencer, "Big Mouth Doctor," accused Juzi Biotechnology of selling a collagen product with insufficient collagen content, claiming it was only 0.0177%, which is below the required 0.1% for non-trace ingredients [3][6]. - Juzi Biotechnology's brand, Kefu Mei, issued a statement denying these allegations, asserting that their tests showed collagen content exceeding 0.1% and that they would conduct further third-party tests to verify this [6]. Group 2: Company Background and Market Position - Juzi Biotechnology, led by its actual controller, Fan Daidi, is a leader in the recombinant collagen field in China, with a product range that includes functional skincare, medical dressings, and medical devices [7]. - The company has seen rapid growth, with revenue increasing from 0.9 billion to 5.5 billion from 2019 to 2024, and net profit rising from 0.55 billion to 2.06 billion during the same period [8]. Group 3: Financial Performance and Market Dynamics - In 2024, Kefu Mei generated 4.54 billion, a year-on-year increase of 62.9%, while another brand, Keli Jin, achieved 0.84 billion, up 36.3% [8]. - Juzi Biotechnology's gross margin is reported at 82%, significantly higher than many comparable companies in the industry, which typically range from 70% to 90% [8]. Group 4: Recent Financing Activities - Despite strong financial performance, Juzi Biotechnology has engaged in multiple financing rounds, including an IPO in 2022 that raised 0.584 billion and a recent placement in 2024 that raised 1.641 billion [9].

Core Viewpoint - The article discusses the rise of Fan Daidi and her husband Yan Jianya as the new richest couple in Shaanxi, primarily due to their holdings in Juzi Biological and Triangle Defense, with a combined market value of nearly 900 billion yuan [2][9]. Group 1: Personal Background and Wealth - Fan Daidi holds a stock value of 443 billion yuan and has recently become the richest person in Shaanxi [2][5]. - The couple's daughter, Yan Yubo, has been rigorously trained and holds multiple financial certifications, currently serving as the secretary and executive director of Juzi Biological, with a salary increase from 140,000 yuan in 2023 to 360,000 yuan in 2024 [3][16]. Group 2: Company Overview - Juzi Biological - Juzi Biological, a leader in the field of recombinant collagen, has seen its revenue grow from 9 billion yuan in 2019 to 55 billion yuan in 2024, marking a fivefold increase over five years [18]. - The company has a projected revenue of 45.4 billion yuan in 2024, with a year-on-year growth of 62.9%, and a gross margin of 82% [17][21]. - Juzi Biological has raised a total of 45.6 billion yuan through various financing rounds since its IPO in 2022, while distributing 2.3 billion yuan in dividends to the Fan family [25] [24]. Group 3: Company Overview - Triangle Defense - Triangle Defense, which specializes in aerospace and military components, has a market value exceeding 100 billion yuan, with Yan Jianya controlling 16.09% of the shares [26][27]. - The company has experienced significant revenue growth from 4.7 billion yuan in 2018 to 24.9 billion yuan in 2023, but has faced a decline in 2024 due to reduced orders from major clients [28]. - Triangle Defense is currently under regulatory scrutiny for various management issues, which could impact its future performance [28].